TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. 2003

Masahiro Yamamoto, and Shintaro Sato, and Hiroaki Hemmi, and Satoshi Uematsu, and Katsuaki Hoshino, and Tsuneyasu Kaisho, and Osamu Takeuchi, and Kiyoshi Takeda, and Shizuo Akira
Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Suita Osaka 565-0871, Japan.

Recognition of pathogens by Toll-like receptors (TLRs) triggers innate immune responses through signaling pathways mediated by Toll-interleukin 1 receptor (TIR) domain-containing adaptors such as MyD88, TIRAP and TRIF. MyD88 is a common adaptor that is essential for proinflammatory cytokine production, whereas TRIF mediates the MyD88-independent pathway from TLR3 and TLR4. Here we have identified a fourth TIR domain-containing adaptor, TRIF-related adaptor molecule (TRAM), and analyzed its physiological function by gene targeting. TRAM-deficient mice showed defects in cytokine production in response to the TLR4 ligand, but not to other TLR ligands. TLR4- but not TLR3-mediated MyD88-independent interferon-beta production and activation of signaling cascades were abolished in TRAM-deficient cells. Thus, TRAM provides specificity for the MyD88-independent component of TLR4 signaling.

UI MeSH Term Description Entries
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000943 Antigens, Differentiation Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation. Differentiation Antigen,Differentiation Antigens,Differentiation Antigens, Hairy Cell Leukemia,Differentiation Marker,Differentiation Markers,Leu Antigen,Leu Antigens,Marker Antigen,Marker Antigens,Markers, Differentiation,Antigen, Differentiation,Antigen, Leu,Antigen, Marker,Antigens, Leu,Antigens, Marker,Marker, Differentiation
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D017472 Receptors, Interleukin-1 Cell surface receptors that are specific for INTERLEUKIN-1. Included under this heading are signaling receptors, non-signaling receptors and accessory proteins required for receptor signaling. Signaling from interleukin-1 receptors occurs via interaction with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88. IL-1 Receptor,IL-1 Receptors,IL1 Receptor,Interleukin-1 Receptor,Interleukin-1 Receptors,Receptor, Interleukin-1,Receptors, IL-1,IL1 Receptors,Interleukin 1 Receptor,IL 1 Receptor,IL 1 Receptors,Interleukin 1 Receptors,Receptor, IL-1,Receptor, IL1,Receptor, Interleukin 1,Receptors, IL 1,Receptors, IL1,Receptors, Interleukin 1

Related Publications

Masahiro Yamamoto, and Shintaro Sato, and Hiroaki Hemmi, and Satoshi Uematsu, and Katsuaki Hoshino, and Tsuneyasu Kaisho, and Osamu Takeuchi, and Kiyoshi Takeda, and Shizuo Akira
May 2006, Circulation research,
Masahiro Yamamoto, and Shintaro Sato, and Hiroaki Hemmi, and Satoshi Uematsu, and Katsuaki Hoshino, and Tsuneyasu Kaisho, and Osamu Takeuchi, and Kiyoshi Takeda, and Shizuo Akira
February 2013, Molecular and cellular biochemistry,
Masahiro Yamamoto, and Shintaro Sato, and Hiroaki Hemmi, and Satoshi Uematsu, and Katsuaki Hoshino, and Tsuneyasu Kaisho, and Osamu Takeuchi, and Kiyoshi Takeda, and Shizuo Akira
May 2005, Infection and immunity,
Masahiro Yamamoto, and Shintaro Sato, and Hiroaki Hemmi, and Satoshi Uematsu, and Katsuaki Hoshino, and Tsuneyasu Kaisho, and Osamu Takeuchi, and Kiyoshi Takeda, and Shizuo Akira
March 2024, The Journal of investigative dermatology,
Masahiro Yamamoto, and Shintaro Sato, and Hiroaki Hemmi, and Satoshi Uematsu, and Katsuaki Hoshino, and Tsuneyasu Kaisho, and Osamu Takeuchi, and Kiyoshi Takeda, and Shizuo Akira
April 2013, Pathogens and disease,
Masahiro Yamamoto, and Shintaro Sato, and Hiroaki Hemmi, and Satoshi Uematsu, and Katsuaki Hoshino, and Tsuneyasu Kaisho, and Osamu Takeuchi, and Kiyoshi Takeda, and Shizuo Akira
December 2012, Brain research,
Masahiro Yamamoto, and Shintaro Sato, and Hiroaki Hemmi, and Satoshi Uematsu, and Katsuaki Hoshino, and Tsuneyasu Kaisho, and Osamu Takeuchi, and Kiyoshi Takeda, and Shizuo Akira
August 2016, Experimental and therapeutic medicine,
Masahiro Yamamoto, and Shintaro Sato, and Hiroaki Hemmi, and Satoshi Uematsu, and Katsuaki Hoshino, and Tsuneyasu Kaisho, and Osamu Takeuchi, and Kiyoshi Takeda, and Shizuo Akira
July 2011, Yonsei medical journal,
Masahiro Yamamoto, and Shintaro Sato, and Hiroaki Hemmi, and Satoshi Uematsu, and Katsuaki Hoshino, and Tsuneyasu Kaisho, and Osamu Takeuchi, and Kiyoshi Takeda, and Shizuo Akira
December 2006, Scandinavian journal of immunology,
Masahiro Yamamoto, and Shintaro Sato, and Hiroaki Hemmi, and Satoshi Uematsu, and Katsuaki Hoshino, and Tsuneyasu Kaisho, and Osamu Takeuchi, and Kiyoshi Takeda, and Shizuo Akira
July 2011, Rheumatology (Oxford, England),
Copied contents to your clipboard!